These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22524471)

  • 1. Effect of parotid gland massage on parotid gland Tc-99m pertechnetate uptake.
    Kim HW; Ahn BC; Lee SW; Lee J
    Thyroid; 2012 Jun; 22(6):611-6. PubMed ID: 22524471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emptying effect of massage on parotid gland radioiodine content.
    Hong CM; Son SH; Kim CY; Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
    Nucl Med Commun; 2014 Nov; 35(11):1127-31. PubMed ID: 25121980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Preventive Effect of Parotid Gland Massage on Salivary Gland Dysfunction During High-Dose Radioactive Iodine Therapy for Differentiated Thyroid Cancer: A Randomized Clinical Trial.
    Son SH; Lee CH; Jung JH; Kim DH; Hong CM; Jeong JH; Jeong SY; Lee SW; Lee J; Ahn BC
    Clin Nucl Med; 2019 Aug; 44(8):625-633. PubMed ID: 31274608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.
    Raza H; Khan AU; Hameed A; Khan A
    Nucl Med Commun; 2006 Jun; 27(6):495-9. PubMed ID: 16710103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance.
    Loutfi I; Nair MK; Ebrahim AK
    J Nucl Med Technol; 2003 Jun; 31(2):81-5. PubMed ID: 12777459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
    Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
    J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased uptake on I-131 whole-body scintigraphy in Warthin tumor despite false-negative Tc-99m pertechnetate salivary gland scintigraphy.
    Caglar M; Tuncel M; Usubutun A
    Clin Nucl Med; 2003 Nov; 28(11):945-6. PubMed ID: 14578721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetic compartment model for evaluating salivary gland scintigraphies.
    Afzelius P; Fuglsang S
    Clin Physiol Funct Imaging; 2014 Mar; 34(2):143-50. PubMed ID: 23909953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased thyroid uptake of Tc-99m pertechnetate in patients with advanced-stage Sjögren syndrome: evaluation using salivary gland scintigraphy.
    Taura S; Murata Y; Aung W; Ishida R; Zhang L; Hossain M; Takahashi Y; Okada N; Shibuya H
    Clin Nucl Med; 2002 Apr; 27(4):265-9. PubMed ID: 11914666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
    Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative remnant
    Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
    Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Bleckmann C; Brenner W; Lassmann S; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Feb; 175(2):57-61. PubMed ID: 10065139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
    Caglar M; Tuncel M; Alpar R
    Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up.
    Wu JQ; Feng HJ; Ouyang W; Sun YG; Chen P; Wang J; Xian JL; Huang LH
    Nucl Med Commun; 2015 Aug; 36(8):819-26. PubMed ID: 25932534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactive iodine and the salivary glands.
    Mandel SJ; Mandel L
    Thyroid; 2003 Mar; 13(3):265-71. PubMed ID: 12729475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.
    Huang EL; Steffen IG; Lukas M; Huang K; Aschenbach JR; Eary JF; Brenner W; Beindorff N
    Nuklearmedizin; 2019 Feb; 58(1):39-49. PubMed ID: 30769372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine.
    Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Tönshoff G; Sippel C; Wolf H; Clausen M; Henze E
    Nucl Med Commun; 1996 Aug; 17(8):681-6. PubMed ID: 8878127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
    Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
    Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of technetium 99m pertechnetate salivary gland scintigraphy in patients with certain salivary gland diseases.
    Wu CB; Xi H; Zhou Q; Zhang LM
    J Oral Maxillofac Surg; 2015 Mar; 73(3):443-50. PubMed ID: 25530280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands.
    Anjos DA; Etchebehere EC; Santos AO; Lima MC; Ramos CD; Paula RB; Camargo EE
    Nucl Med Commun; 2006 Apr; 27(4):395-403. PubMed ID: 16531928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.